Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 11 04:00PM ET
6.41
Dollar change
-0.17
Percentage change
-2.58
%
Index- P/E- EPS (ttm)-2.55 Insider Own9.50% Shs Outstand43.31M Perf Week-0.77%
Market Cap277.62M Forward P/E- EPS next Y-1.33 Insider Trans-0.22% Shs Float39.20M Perf Month14.87%
Income-52.60M PEG- EPS next Q-0.38 Inst Own75.46% Short Float6.80% Perf Quarter18.92%
Sales0.00M P/S- EPS this Y41.60% Inst Trans447.50% Short Ratio8.81 Perf Half Y-15.10%
Book/sh1.76 P/B3.65 EPS next Y9.64% ROA-56.09% Short Interest2.67M Perf Year50.47%
Cash/sh2.84 P/C2.26 EPS next 5Y- ROE-127.38% 52W Range3.05 - 9.01 Perf YTD27.94%
Dividend Est.- P/FCF- EPS past 5Y38.92% ROI-56.93% 52W High-28.86% Beta1.51
Dividend TTM- Quick Ratio7.48 Sales past 5Y-15.07% Gross Margin13.31% 52W Low110.16% ATR (14)0.30
Dividend Ex-Date- Current Ratio7.48 EPS Y/Y TTM30.17% Oper. Margin0.00% RSI (14)61.16 Volatility4.04% 5.24%
Employees84 Debt/Eq0.32 Sales Y/Y TTM-100.00% Profit Margin- Recom1.00 Target Price15.92
Option/ShortYes / Yes LT Debt/Eq0.26 EPS Q/Q71.60% Payout- Rel Volume0.68 Prev Close6.58
Sales Surprise-100.00% EPS Surprise23.98% Sales Q/Q-100.00% EarningsAug 12 BMO Avg Volume302.65K Price6.41
SMA205.10% SMA5015.01% SMA20014.91% Trades Volume207,299 Change-2.58%
Date Action Analyst Rating Change Price Target Change
Jul-03-24Initiated H.C. Wainwright Buy $15
May-30-24Initiated Stifel Buy $21
Nov-11-20Upgrade Cantor Fitzgerald Neutral → Overweight $4
Sep-18-20Initiated B. Riley FBR Buy $5
Feb-10-20Initiated SVB Leerink Outperform $6
Dec-10-19Resumed Cantor Fitzgerald Neutral $2 → $4
Aug-15-19Downgrade Maxim Group Buy → Hold
Aug-12-19Downgrade Cantor Fitzgerald Overweight → Neutral $29 → $2
Jul-26-19Downgrade Mizuho Buy → Neutral $17 → $4
Jun-27-19Initiated Mizuho Buy
Oct-09-24 06:13PM
Oct-01-24 07:30AM
Sep-03-24 07:30AM
Sep-02-24 07:30AM
Aug-14-24 07:30AM
07:30AM Loading…
Aug-13-24 07:30AM
Aug-12-24 07:37AM
07:30AM
Aug-01-24 07:30AM
Jul-11-24 07:30AM
Jul-08-24 07:30AM
Jun-21-24 03:08AM
Jun-03-24 07:30AM
May-28-24 07:30AM
May-16-24 03:01AM
02:17AM Loading…
02:17AM
May-15-24 12:53PM
07:43AM
07:30AM
May-07-24 07:30AM
May-03-24 11:19AM
07:30AM
Apr-23-24 02:04PM
08:53AM
07:39AM
07:09AM
Apr-22-24 05:58PM
04:27PM
04:14PM
04:05PM
08:30AM Loading…
Apr-01-24 08:30AM
Mar-19-24 06:53AM
05:31AM
Mar-18-24 07:30AM
Mar-05-24 07:30AM
Feb-15-24 05:52AM
Feb-01-24 04:05PM
07:30AM
Jan-08-24 07:30AM
Dec-15-23 07:30AM
Nov-27-23 07:30AM
Nov-17-23 10:09AM
Nov-14-23 04:29AM
Nov-13-23 12:23PM
07:41AM
07:30AM
Nov-01-23 07:30AM
Sep-26-23 07:30AM
Sep-12-23 12:48PM
07:30AM
Sep-07-23 07:30AM
Aug-30-23 07:30AM
Aug-11-23 07:41AM
Aug-08-23 08:27AM
07:30AM
Jul-28-23 07:30AM
Jul-19-23 08:30AM
Jul-07-23 08:30AM
Jul-03-23 08:45AM
Jun-09-23 07:30AM
Jun-01-23 07:30AM
May-30-23 08:00AM
May-25-23 12:27AM
May-22-23 07:30AM
May-16-23 09:00AM
May-13-23 08:15AM
May-11-23 07:54AM
07:30AM
07:00AM
Apr-18-23 07:15AM
Apr-10-23 07:30AM
Mar-31-23 06:22AM
Mar-29-23 07:30AM
Mar-24-23 07:30AM
Mar-16-23 07:30AM
Mar-14-23 07:30AM
Nov-14-22 07:30AM
Nov-08-22 02:28PM
Nov-03-22 12:44PM
07:31AM
07:30AM
Oct-19-22 07:30AM
Oct-04-22 07:30AM
Sep-22-22 07:30AM
Sep-13-22 07:30AM
Sep-08-22 08:48AM
Aug-11-22 07:30AM
Jul-20-22 07:30AM
Jun-24-22 10:08AM
Jun-13-22 01:27PM
Jun-10-22 03:30PM
Jun-08-22 01:21PM
Jun-06-22 02:04PM
07:30AM
Jun-01-22 02:25PM
May-31-22 02:27PM
May-25-22 02:29PM
May-23-22 03:32PM
May-19-22 03:02PM
07:30AM
Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Alvino MarkDirectorJun 18 '24Sale4.5125,890116,76436,926Jun 20 04:30 PM
Silverstein Christine BerniDirectorJun 18 '24Sale4.5125,821116,45362,063Jun 20 04:30 PM
Alland LeilaDirectorMay 16 '24Buy4.7111,00051,79982,857May 20 08:30 AM
Seshadri VishwasChief Executive OfficerApr 25 '24Buy3.2010,00032,000538,260Apr 29 08:30 AM
Charles Faith L.DirectorApr 26 '24Buy3.287,55024,76478,323Apr 29 08:30 AM
O'Malley Brendan M.SVP, General CounselApr 25 '24Buy3.248,60027,864188,718Apr 26 08:30 AM
Vazzano Joseph WalterChief Financial OfficerApr 25 '24Buy3.145,60817,609233,868Apr 26 08:30 AM
Seshadri VishwasChief Executive OfficerFeb 06 '24Buy4.3920,00087,800528,260Feb 07 08:30 AM
Alvino MarkDirectorJan 17 '24Sale5.117,08436,19962,816Jan 22 04:30 PM